trending Market Intelligence /marketintelligence/en/news-insights/trending/acowhar7xtzketmvmwt5ga2 content esgSubNav
In This List

Therapure Biopharma's biologics unit plans IPO

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery


Therapure Biopharma's biologics unit plans IPO

Therapure Biopharma Inc..'s biologics division, Evolve Biologics, confidentially submitted a draft registration statement for an IPO in the U.S.

The IPO is expected to commence after the U.S. Securities and Exchange Commission completes its review process, subject to market and other conditions.

The Mississauga, Canada-based privately held company's biologics unit separates proteins from blood's plasma for use in treating diseases.